Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R-Reference-Cited by-同舟云学术

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R

Published:2017-10-29 Issue:5 Volume:179 Page:739-747
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Giulino-Roth Lisa¹²^ORCID,O'Donohue Tara¹,Chen Zhengming³,Bartlett Nancy L.⁴,LaCasce Ann⁵,Martin-Doyle William⁶,Barth Matthew J.⁷,Davies Kimberly⁸,Blum Kristie A.⁹,Christian Beth⁹,Casulo Carla¹⁰,Smith Sonali M.¹¹,Godfrey James¹¹,Termuhlen Amanda¹²,Oberley Matthew J.¹³,Alexander Sarah¹⁴,Weitzman Sheila¹⁴,Appel Burton¹⁵,Mizukawa Benjamin¹⁶,Svoboda Jakub¹⁷,Afify Zeinab¹⁸,Pauly Melinda¹⁹²⁰,Dave Hema²¹,Gardner Rebecca²²,Stephens Deborah M.²³,Zeitler William A.²⁴,Forlenza Christopher²⁵,Levine Jennifer²⁶,Williams Michael E.²⁷,Sima Jody L.²⁸,Bollard Catherine M.²¹,Leonard John P.²

Affiliation:

1. Department of Pediatrics; Weill Cornell Medicine and New York Presbyterian Hospital; New York NY USA

2. Department of Medicine; Weill Cornell Medicine and New York Presbyterian Hospital; New York NY USA

3. Healthcare Policy and Research Meyer Cancer Center; Weill Cornell Medicine and New York Presbyterian Hospital; New York NY USA

4. Department of Medicine; Washington University School of Medicine; St. Louis MO USA

5. Medical Oncology; Dana Farber Cancer Institute; Boston MA USA

6. Department of Medicine; Brigham and Women's Hospital; Boston MA USA

7. Department of Pediatrics; Roswell Park Cancer Institute and University at Buffalo; Buffalo NY USA

8. Department of Pediatric Oncology; Dana-Farber Cancer Institute and Boston Children's Hospital; Boston MA USA

9. Division of Hematology; The Ohio State University and Arthur G. James Cancer Hospital; Columbus OH USA

10. Department of Medicine; University of Rochester Medical Center; Rochester NY USA

11. Department of Medicine; University of Chicago; Chicago IL USA

12. Department of Pediatrics; Keck School of Medicine; Los Angeles CA USA

13. Department of Pathology and Laboratory Medicine; Keck School of Medicine at the University of Southern California; Children's Hospital Los Angeles; Los Angeles CA USA

14. Division of Haematology/Oncology; Hospital for Sick Children; Toronto ON Canada

15. Institute for Pediatric Cancer & Blood Disorders; Joseph M. Sanzari Children's Hospital; Hackensack University Medical Center; Hackensack NJ USA

16. Cincinnati Children's Hospital Medical Center; Cincinnati OH USA

17. Lymphoma Program; Abramson Cancer Center; University of Pennsylvania; Philadelphia PA USA

18. Department of Pediatrics; University of Utah; Salt Lake City UT USA

19. Department of Pediatrics; Emory University; Atlanta GA USA

20. Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta; Atlanta GA USA

21. Department of Pediatrics; The George Washington University and Children's National Health System; Washington DC USA

22. Seattle Children's Hospital; University of Washington; Seattle WA USA

23. Department of Medicine; University of Utah; Salt Lake City UT USA

24. Department of Medicine; University of Iowa; Iowa City IA USA

25. Department of Pediatrics; Memorial Sloan Kettering Cancer Center; New York NY USA

26. Department of Pediatrics; Columbia University Medical Center and New York Presbyterian Hospital; New York NY USA

27. Hematology/Oncology Division and Cancer Center; University of Virginia School of Medicine; Charlottesville VA USA

28. Department of Pediatrics; Upstate Medical University; Syracuse NY USA

Funder

St. Baldrick's Foundation

Hyundai Hope On Wheels

Lymphoma Foundation

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14951/fullpdf

Reference29 articles.

1. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;Journal of Clinical Oncology,2014

2. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy;Binkley;Leukaemia & Lymphoma,2016

3. Functional imaging using 18-fluorodeoxyglucose PET in the management of primary mediastinal large B-cell lymphoma: the contributions of the International Extranodal Lymphoma Study Group;Cavalli;American Society of Clinical Oncology educational Book,2016

4. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma;Dunleavy;New England Journal of Medicine,2013

5. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes;Feuerhake;Blood,2005

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergency management of a 13-year-old patient with primary mediastinal B cell lymphoma: Extracorporeal membrane oxygenation and superior vena cava stent prior to chemotherapy;Pediatric Hematology Oncology Journal;2024-09

2. Isolated central nervous system relapse in two adolescents with primary mediastinal large B‐cell lymphoma after treatment with R‐DA‐EPOCH;Pediatric Blood & Cancer;2024-05-09

3. Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders;Biomedicines;2024-04-29

4. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12

5. Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation;Applied Health Economics and Health Policy;2023-11-28